FDA-Inspected Site

Reproductive Medicine Associates Of Philadelphia, P.c.

8 FDA inspections are on record for Reproductive Medicine Associates Of Philadelphia, P.c. in Abington, United States.

Clean· No action indicated

Abington, United States · Last updated July 10, 2026

Overview

  • 8 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2025-12-04.

At a glance

Inspections

8

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
4 Dec 2025BiologicsClean
5 Apr 2023BiologicsClean
11 Mar 2020BiologicsClean
5 Dec 2017 – 6 Dec 2017BiologicsClean
23 Sep 2014BiologicsClean
2 Mar 2012Not recordedClean
25 Mar 2010Not recorded483View 483 →
18 Jan 2007Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

25 Mar 2010
21 CFR 1271.47(a)

Procedures for all other requirements

Cited by Gayle S Lawson, Linda M Hoover

25 Mar 2010
21 CFR 1271.50(a)

Determination based on screening and testing

Cited by Gayle S Lawson, Linda M Hoover

25 Mar 2010
21 CFR 1271.50(b)(1)

Donor screening standards

Cited by Gayle S Lawson, Linda M Hoover

25 Mar 2010
21 CFR 1271.55(b)(2)

Listing and interpretation of CD tests performed

Cited by Gayle S Lawson, Linda M Hoover

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 1271.47(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.50(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.50(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 1271.55(b)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind this site's 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat